Reply to the Comment on "Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone

Jia-Xing Lu1, Hai-Rong Lan1, Dai Zeng1

  • 1School of Pharmacy, Henan University of Chinese Medicine Zhengzhou 450046 China hnxap@hactcm.edu.cn 18515912322@163.com hnzz_yuan@hactcm.edu.cn.

RSC Advances
|November 24, 2025
PubMed